Q2 2026 saw record revenues exceeding $950 million, driven by strong performances from INGREZZA, CRENESSITY, and the newly acquired VYKAT XR. The company raised full-year guidance, advanced its pipeline, and maintained robust financial health with no debt and significant cash reserves.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.